Evidence is extremely limited for AOD-9604 safety data. The available research consists primarily of detection methods for doping control and a single animal study, with no comprehensive human safety trials identified.

Known Side Effects

No systematic human safety studies were found in the literature. The limited available evidence does not provide reliable data on side effects or adverse reactions in humans.

Animal Safety Data

One rabbit study examined intra-articular injection of AOD-9604 for osteoarthritis. However, this single animal study provides insufficient evidence to establish a human safety profile or predict clinical side effects.

Contraindications

No established contraindications are documented in the available literature due to the absence of comprehensive clinical safety studies.

Drug Interactions

No drug interaction data were identified in the reviewed evidence. The potential for interactions with other medications remains unknown.

Populations That Should Avoid Use

Without adequate safety data, no specific populations can be definitively identified as requiring avoidance, though standard precautions would suggest:

Pregnant and breastfeeding women (no safety data available)
Children (no pediatric safety data)
Individuals with underlying medical conditions (safety profile unknown)

Regulatory Status

The literature indicates AOD-9604 has been subject to doping control testing in athletic settings, suggesting it may be a prohibited substance in competitive sports.

Critical Safety Limitations

The evidence base for AOD-9604 safety is severely inadequate. No human clinical trials, phase I safety studies, or systematic adverse event reporting were identified. The available literature focuses primarily on analytical detection methods rather than clinical safety evaluation.

This information is for educational purposes only and should not replace professional medical advice. Consult with a healthcare provider before considering any peptide therapy.

AOD-9604